Statements (55)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Buprenorphine
|
| gptkbp:appointed_by |
under medical supervision
sublingual administration |
| gptkbp:approves |
gptkb:2002
gptkb:FDA |
| gptkbp:can_be_used_with |
counseling and behavioral therapies
|
| gptkbp:caused_by |
withdrawal symptoms
drowsiness |
| gptkbp:contains |
gptkb:naloxone
gptkb:buprenorphine |
| gptkbp:contraindication |
severe respiratory depression
hypersensitivity to buprenorphine or naloxone |
| gptkbp:developed_by |
gptkb:Reckitt_Benckiser
|
| gptkbp:discontinued |
abruptly
|
| gptkbp:dosage_form |
film strip
|
| gptkbp:duration |
varies by patient
|
| gptkbp:form |
sublingual film
|
| https://www.w3.org/2000/01/rdf-schema#label |
Suboxone film
|
| gptkbp:interacts_with |
gptkb:beer
CNS depressants benzodiazepines antiretroviral drugs |
| gptkbp:is |
a cure for addiction
|
| gptkbp:is_available_in |
various strengths
film and tablet forms |
| gptkbp:is_available_on |
generic version
|
| gptkbp:is_considered |
a partial agonist medication
a safer alternative to full agonist opioids |
| gptkbp:is_designed_to |
non-medical use
|
| gptkbp:is_effective_against |
preventing relapse
|
| gptkbp:is_maintained_by |
out of reach of children
|
| gptkbp:is_monitored_by |
liver function
|
| gptkbp:is_part_of |
medication-assisted treatment
a comprehensive treatment strategy opioid addiction recovery plans |
| gptkbp:is_subject_to |
abuse potential
|
| gptkbp:is_used_by |
physicians
|
| gptkbp:is_used_for |
treatment of opioid addiction
|
| gptkbp:is_used_in |
opioid dependence treatment programs
|
| gptkbp:is_used_to |
reduce cravings for opioids
|
| gptkbp:marketed_as |
gptkb:Indivior
|
| gptkbp:packaging |
child-resistant packaging
|
| gptkbp:requires |
dose adjustments
|
| gptkbp:side_effect |
headache
nausea insomnia constipation sweating |
| gptkbp:storage |
at room temperature
|
| gptkbp:suitable_for |
pregnant women without medical advice
patients with severe liver impairment methadone in some cases patients with a history of hypersensitivity reactions. |